Bio-Techne Corporation
TECHNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $11.39B
- P/E (TTM)
- 62.61
- Forward P/E
- 31.27
- Dividend yield
- 1.45%
- 52-week range
- $43.20$72.69
- Volume (live)
- -
- Avg. volume (3M)
- 2.98M
Bio-Techne (TECH) Stock Price & Financial Analysis
Bio-Techne Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $72.50 - $72.61 |
|---|---|
| 52-Week High | $72.69 |
| 52-Week Low | $43.20 |
| Open | $72.53 |
| Volume (last close) | 2.40M |
| Average Volume (3M) | 2.98M |
| Revenue (TTM) | 1.22B |
|---|---|
| Net Income (TTM) | 181.86M |
| Free Cash Flow (TTM) | 263.22M |
| EPS (TTM) | $1.16 |
| Profit Margin | 14.97% |
| Operating Margin | 20.73% |
| Return on Equity (ROE) | 8.63% |
| Debt to Equity | 0.14 |
| Annual Dividend | $1.05 |
|---|---|
| Dividend Yield | 1.45% |
| Payout Ratio | 90.55% |
| Last Dividend Ex-Date | Sep 4, 2026 |
| Market Cap | 11.39B |
|---|---|
| Shares Outstanding | 157.01M |
| P/E Ratio (TTM) | 62.61 |
| Forward P/E | 31.27 |
| Price to Sales (P/S) | 9.37 |
| Price to Book (P/B) | 5.40 |
| EV/EBITDA | 33.22 |
| 50-Day MA | $72.36 |
|---|---|
| 200-Day MA | $62.61 |
| 1-Year Change | +17.73% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Bio-Techne at a Glance
As of the Oct 15, 2026 close, Bio-Techne (TECH) has a market capitalization of $11.39B. The stock trades at 62.6× trailing earnings, 31.3× forward earnings and 9.4× sales. Over the trailing twelve months it earned $181.86M on revenue of $1.22B (a 15.0% profit margin) and generated $263.22M of free cash flow. Revenue fell 0.4% year over year.
As of its latest reported balance sheet, it holds $264.71M in cash and securities against $289.09M of debt, a net debt position of $24.38M.
Bio-Techne pays a quarterly dividend totaling $1.05 per share a year, a 1.45% yield at the Oct 15, 2026 close, with a 91% payout ratio.
The share price is up 17.7% over the past year. At $72.52 (the Oct 15, 2026 close) it sits near the top of its 52-week range of $43.20 to $72.69, above its 200-day moving average of $62.61.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $73.00, 0.7% above the Oct 15, 2026 close.
Frequently Asked Questions About Bio-Techne
What is the current stock price for TECH?
As of the Oct 15, 2026 close, TECH stock trades at $72.52. The 52-week range is $43.20–$72.69, with a day range of $72.50–$72.61.
What is the P/E ratio for TECH?
As of the Oct 15, 2026 close, Bio-Techne's trailing twelve-month (TTM) P/E ratio is 62.6, meaning investors pay $62.6 for every $1 of annual earnings. The forward P/E is 31.3, reflecting analyst expectations for future earnings. Bio-Techne operates in the Healthcare sector.
Does TECH pay dividends?
Yes, Bio-Techne pays a 1.45% annual dividend yield as of the Oct 15, 2026 close ($1.05 per share a year). The trailing twelve-month payout ratio is 90.5%. The most recent ex-dividend date was September 4, 2026.
What do analysts recommend for TECH?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for TECH is Hold. The average 12-month price target is $73.00, a 0.7% upside from the Oct 15, 2026 close of $72.52.
What is the market cap of TECH?
As of the Oct 15, 2026 close, Bio-Techne's market capitalization is $11.39B, classifying it as a large-cap company. Bio-Techne operates in the Healthcare sector within the Biotechnology industry.